| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 09/14/2011 | CN102181282A Cavity transfer material with triphenylamine-bipyridyl structure and preparation method thereof |
| 09/14/2011 | CN102180911A Nitrogen-oxygen ligand with planar chirality and central chirality and metal complex thereof |
| 09/14/2011 | CN102180829A Surface-modified pyridine thioketone salt and application thereof |
| 09/14/2011 | CN102180826A Histone deacetylase inhibitor containing alpha amino acid structure and application thereof |
| 09/14/2011 | CN101786997B Amino acid and pesticide coupling compound as well as preparation method and application thereof as pesticide |
| 09/14/2011 | CN101701021B Rare earth lanthanum chelidonamic acid complex and preparation method thereof |
| 09/14/2011 | CN101580488B Preparation method and application of tridentate pyridine imine ligand |
| 09/14/2011 | CN101538240B Method for recycling solid wastes in carbonate production |
| 09/14/2011 | CN101367791B Insecticidal active compound |
| 09/14/2011 | CN101233110B Substance with oxidation resistance, agedness protection and anti-ischemia active and preparing method thereof |
| 09/13/2011 | US8017776 Methods for synthesis of acyloxyalkyl compounds |
| 09/13/2011 | US8017630 Cyclohexylacetic acid compounds |
| 09/13/2011 | US8017628 Pharmaceutically active sulfonyl hydrazide derivatives |
| 09/13/2011 | US8017621 Inhibitors of the mutant form of kit |
| 09/13/2011 | US8016940 Processing method for organic crystal, processing device for organic crystal, and observing device for organic crystal |
| 09/13/2011 | CA2619077C Methods for the preparation of hcv polymerase inhibitors |
| 09/13/2011 | CA2582276C Alkil-pyridines as 11-beta inhibitors for diabetes |
| 09/13/2011 | CA2486869C Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 09/13/2011 | CA2425268C Pyridinone derivatives for treatment of atherosclerosis |
| 09/13/2011 | CA2396937C Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils |
| 09/13/2011 | CA2309260C 2,4-substituted pyrimidines and their use in herbicidal compositions |
| 09/09/2011 | WO2011108963A1 Urethanes, ureas, amidines and related inhibitors of factor xa |
| 09/09/2011 | WO2011108724A1 Prophylactic or therapeutic agent for diabetes or obesity |
| 09/09/2011 | WO2011108696A1 Method for producing α-acyloxycarbonyl compound and novel α-acyloxycarbonyl compound |
| 09/09/2011 | WO2011108690A1 Alkylamine derivative |
| 09/09/2011 | WO2011108512A1 Novel azomethine oligomer |
| 09/09/2011 | WO2011108009A2 Process for the preparation of fampridine |
| 09/09/2011 | WO2011107843A2 Process for the preparation of atazanavir sulfate substantially free of diastereomers |
| 09/09/2011 | WO2011107608A1 Heterocyclic amides as rock inhibitors |
| 09/09/2011 | WO2011076711A3 Polymorphs of salts of 4- [4- [ [4-chloro-3- (trifluoromethyl) phenyl] carbamoylamino] phenoxy] -n-methylpyridine - 2 - carboxamide |
| 09/09/2011 | CA2791875A1 Urethanes, ureas, amidines and related inhibitors of factor xa |
| 09/09/2011 | CA2791680A1 Compounds and therapeutic uses thereof |
| 09/09/2011 | CA2791338A1 Heterocyclic amides as rock inhibitors |
| 09/09/2011 | CA2791174A1 Alkylamine derivative |
| 09/08/2011 | US20110218340 2-[1-Cyanopropyl)Carbamoyl]-5-Chloromethyl Nicotinic Acids and the Use Thereof in Manufacturing Herbicidal Imidazolinones |
| 09/08/2011 | US20110218221 Novel histone deacetylase inhibitors, process for preparation and uses thereof |
| 09/08/2011 | US20110218220 Rationally improved isoniazid and ethionamide derivatives and activity through selective isotopic substitution |
| 09/08/2011 | US20110218219 Substituted sulphonamido phenoxybenzamides |
| 09/08/2011 | US20110218214 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
| 09/08/2011 | US20110218208 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases |
| 09/08/2011 | US20110218199 Pyridoneamide derivatives, their manufacture and use as pharmaceutical agents |
| 09/08/2011 | US20110217783 Cleavable surfactants and methods of use thereof |
| 09/07/2011 | EP2363393A1 Compounds and compositions as hedgehog pathway modulators |
| 09/07/2011 | EP2363392A1 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques |
| 09/07/2011 | EP2363391A1 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques |
| 09/07/2011 | EP2362730A1 Adamantyl benzamide compounds |
| 09/07/2011 | EP2100605B1 Bis(thio-hydrazide amide) compounds in combination with taxol for treating cancer |
| 09/07/2011 | EP1841756B1 3-heterocyclyl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity |
| 09/07/2011 | EP1801102B1 Process for production of 2-hydroxy-4-substituted pyridines |
| 09/07/2011 | CN102175750A Method for analyzing biological samples by using matrix assisted laser desorption ionization-Fourier transform ion cyclotron resonance mass spectra |
| 09/07/2011 | CN102174014A Preparation method of 3-chloropyridine |
| 09/07/2011 | CN102174013A New synthesis technology of acetamiprid |
| 09/07/2011 | CN102173987A New manchurian walnut bark acid and derivatives thereof, and preparation methods and medical application thereof |
| 09/07/2011 | CN102173432A Macroporous molecular sieve, preparation method and application in pyridylmethyl amine preparation |
| 09/07/2011 | CN102172525A Gold nano catalyst and preparation method thereof, and preparation method of amide compounds |
| 09/07/2011 | CN101654430B Broadband electron transport material and preparation and application |
| 09/07/2011 | CN101565409B Piperazidine or homopiperazine oxalyl hydrazine class compound, preparation and use thereof |
| 09/07/2011 | CN101389607B Substituted arylsulfonamides as antiviral agents |
| 09/07/2011 | CN101304971B Pharmaceutical salts and polymorphs of n- (5-chl0r0-2-pyridinyl) -2- [ [4- [ (dimethylamino) iminomethyl] benzoyl] amino] -5-meth oxy-benzamide, a factor xa inhibitor |
| 09/07/2011 | CN101263151B Process for production of ortho-metallized complex of iridium with homoligand |
| 09/07/2011 | CN101215261B Method for synthesizing of 2-oxo-3-pyridine formic acid ester and derivatives thereof |
| 09/07/2011 | CN101203493B Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them |
| 09/07/2011 | CN101061101B Aroylfuranes and aroylthiophenes suitable |
| 09/06/2011 | US8013241 Ionic gel electrolyte, dye-sensitized photoelectric conversion device and solar cell |
| 09/06/2011 | US8013183 Alpha ketoamide compounds as cysteine protease inhibitors |
| 09/06/2011 | US8013001 Modulators of LXR |
| 09/06/2011 | US8012995 Pharmaceutically active sulfonamide derivatives |
| 09/06/2011 | US8012972 Pyridinecarboxylic acid (2-aminophenyl) amide derivative having urea structure |
| 09/06/2011 | CA2488642C Aryl carbonyl derivatives as glucokinase activators |
| 09/06/2011 | CA2373360C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 09/01/2011 | WO2011105521A1 Metal complex, and adsorbent, occlusion material and separator material made from same |
| 09/01/2011 | WO2011105373A1 Substituted pyridyl compound and organic electroluminescent element |
| 09/01/2011 | WO2011104333A1 Composition for oxidation of organic substrates |
| 09/01/2011 | WO2011104203A1 Compounds as bradykinin b1 antagonists |
| 09/01/2011 | WO2010088842A8 Pharmaceutical compositions containing pyridyl cyanoguanidines, preparation methods and uses thereof |
| 09/01/2011 | US20110213157 Tricyclic amide compound |
| 09/01/2011 | US20110213029 3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands |
| 09/01/2011 | US20110213002 Macrocyclic diterpenes for treating conditions associated with protein kinase c |
| 09/01/2011 | US20110212968 Phenethylamide derivatives and their heterocyclic analogues |
| 09/01/2011 | US20110212945 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 09/01/2011 | US20110212026 Butyrylcholinesterase ligands as diagnostic tools and treatment for deseases of the nervous system |
| 09/01/2011 | CA2790952A1 Compounds as bradykinin b1 antagonists |
| 09/01/2011 | CA2788961A1 Metal complex, and adsorbent, occlusion material and separator material made from same |
| 08/31/2011 | EP2361913A1 Anti-infective agents |
| 08/31/2011 | EP2361905A1 Heterocyclic Inhibitors of MEK and methods of use thereof |
| 08/31/2011 | EP2361902A1 4,6-diaminonicotinamide compound |
| 08/31/2011 | EP2361247A2 Flupirtine hydrochloride maleic acid cocrystal |
| 08/31/2011 | EP2361243A2 Haloalkyl containing compounds as cysteine protease inhibitors |
| 08/31/2011 | EP2203426B1 Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 08/31/2011 | CN1835922B Process for preparation of 4-aryl-nicotinamide derivatives |
| 08/31/2011 | CN102171189A Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists |
| 08/31/2011 | CN102171188A Tripyridyl carboxamide orexin receptor antagonists |
| 08/31/2011 | CN102171183A Organic compounds |
| 08/31/2011 | CN102170872A Method of modulating membrane potential of a cell |
| 08/31/2011 | CN102167683A Bivalent cation magnetic ionic liquids and preparation method thereof |
| 08/31/2011 | CN101638352B Aryl-replaced nitrogen heterocyclic compound preparation method |
| 08/31/2011 | CN101575735B Pyridine-2,4,6-triformate manganese ferro-electrical functional material and preparation method thereof |
| 08/31/2011 | CN101391979B Unsymmetrical bis(imino)pyridines iron and cobalt complexes containing halogen, preparation method and use |
| 08/31/2011 | CN101268051B Isotopically substituted proton pump inhibitors |
| 08/30/2011 | US8008525 For the 14273 peroxisome proliferator activated receptor; antidiabetic agents, hyperlipidemia, obesity or anorexia; receptor binding assay; drug screening kits |